Clinical Trial

Immune Spatial Features of Guselkumab Cutaneous Response

Name: Immune Spatial Features of Guselkumab Cutaneous Response — clinical trial record (NCT05858632)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study examines the effect of IL-23 blockade with Guselkumab on the immune cells of scalp psoriasis lesions.

Trial Details

NCT Number	NCT05858632
Lead Sponsor	University of California, San Francisco Collaborators: Janssen Scientific Affairs, LLC
Conditions	Psoriasis of Scalp
Enrollment	10 participants
Start Date	2023-07-01
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-04